Axa’s Lemonade LMND Stock Holding History

Axa’s Portfolio LMND Stock Details LMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-67,167	Closed	-$2.83M	–	1215
2021 Q4	$2.83M	Buy	+67,167	New	+$3.77M	0.01%	780
2021 Q1	–	Sell	-1,540,763	Closed	-$189M	–	1280
2020 Q4	$189M	Sell	1,540,763 -758,884	-33%	-$56M	0.59%	25
2020 Q3	$114M	Buy	+2,299,647	New	+$144M	0.41%	46

Other funds holding LMND

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Axa's LMND Position: Q1 2022 in Review

Axa sold out of Lemonade (LMND) in Q1 2022, closing a stake of 67,167 shares — an estimated $2.83M sold.

Axa first reported a position in LMND in Q3 2020 and held it in 3 quarters. The position peaked at $189M in Q4 2020. 237 funds tracked by Wall St. Rank hold LMND as of Q1 2022.

Axa reported no remaining Lemonade position as of Q1 2022 after selling out during the quarter.
Axa sold 67,167 Lemonade shares in Q1 2022, an estimated $2.83M.
Axa first reported a position in Lemonade in Q3 2020 and held it in 3 quarters.
Axa's Lemonade position peaked at $189M in Q4 2020.
237 funds tracked by Wall St. Rank held Lemonade as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.